Английская Википедия:Biostrophin

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Multiple issues

Biostrophin is a drug which may serve as a vehicle for gene therapy, in the treatment of Duchenne and Becker muscular dystrophy.[1]

As mutations in the gene which codes for the protein dystrophin is the underlying defect responsible for both disorders, biostrophin will deliver a genetically-engineered, functional copy of the gene at the molecular level to affected muscle cells.[1] Dosage, as well as a viable means for systemic release of the drug in patients, is currently being investigated with the use of both canine and primate animal models.[2]

Biostrophin is being manufactured by Asklepios BioPharmaceuticals, Inc., with funding provided by the Muscular Dystrophy Association.[3]

See also

Other drugs for Duchenne muscular dystrophy

References

Шаблон:Reflist

External links


Шаблон:Musculoskeletal-drug-stub Шаблон:Genetics-stub Шаблон:Bioengineering-stub